Daniela Moïsi

3.5k total citations · 1 hit paper
68 papers, 2.6k citations indexed

About

Daniela Moïsi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Daniela Moïsi has authored 68 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 56 papers in Virology and 15 papers in Epidemiology. Recurrent topics in Daniela Moïsi's work include HIV Research and Treatment (56 papers), HIV/AIDS drug development and treatment (50 papers) and HIV/AIDS Research and Interventions (34 papers). Daniela Moïsi is often cited by papers focused on HIV Research and Treatment (56 papers), HIV/AIDS drug development and treatment (50 papers) and HIV/AIDS Research and Interventions (34 papers). Daniela Moïsi collaborates with scholars based in Canada, United States and Uganda. Daniela Moïsi's co-authors include Mark A. Wainberg, Bluma Brenner, Maureen Oliveira, Michel Roger, Jean‐Pierre Routy, Michel Ntemgwa, Mervi Detorio, Hugues Charest, Dan Turner and Cécile Tremblay and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Daniela Moïsi

64 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection

2007 501 citations Bluma Brenner, Michel Roger et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniela Moïsi Canada	27	2.4k	2.2k	654	245	154	68	2.6k
Laurence Vergne France	25	1.5k 0.6×	1.5k 0.7×	569 0.9×	102 0.4×	77 0.5×	33	1.9k
Brian Wynhoven Canada	21	1.7k 0.7×	1.5k 0.7×	448 0.7×	281 1.1×	362 2.4×	30	2.1k
Diane Descamps France	35	3.3k 1.4×	3.1k 1.4×	693 1.1×	283 1.2×	223 1.4×	140	3.8k
Sharon Cassol United States	27	1.4k 0.6×	1.3k 0.6×	699 1.1×	213 0.9×	294 1.9×	48	2.2k
Bernard Masquelier France	30	2.1k 0.9×	1.9k 0.8×	399 0.6×	181 0.7×	140 0.9×	85	2.3k
Winnie Dong Canada	25	1.6k 0.7×	1.5k 0.7×	413 0.6×	287 1.2×	109 0.7×	59	2.0k
Vadim Pokrovsky Russia	16	1.0k 0.4×	872 0.4×	563 0.9×	100 0.4×	190 1.2×	53	1.4k
Ruth Dickover United States	20	996 0.4×	1.1k 0.5×	483 0.7×	115 0.5×	146 0.9×	26	1.5k
Benoît Trottier Canada	19	1.7k 0.7×	1.5k 0.7×	390 0.6×	252 1.0×	374 2.4×	68	2.2k
Leslie Jonas United States	10	1.7k 0.7×	1.7k 0.7×	486 0.7×	142 0.6×	234 1.5×	11	2.2k

Countries citing papers authored by Daniela Moïsi

Since Specialization

Citations

This map shows the geographic impact of Daniela Moïsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Moïsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Moïsi more than expected).

Fields of papers citing papers by Daniela Moïsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Moïsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Moïsi. The network helps show where Daniela Moïsi may publish in the future.

Co-authorship network of co-authors of Daniela Moïsi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Moïsi. A scholar is included among the top collaborators of Daniela Moïsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Moïsi. Daniela Moïsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freeman, Michael L., Brian Clagett, Konstantin Leskov, et al.. (2025). Interleukin-2 is a potent latency reversal agent in people with treated HIV-1. Science Advances. 11(51). eaea4268–eaea4268.

Henrich, Timothy J., Ronald J. Bosch, Catherine Godfrey, et al.. (2024). Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV. Cell Reports Medicine. 5(10). 101745–101745. 5 indexed citations

Parikh, Urvi M., Amy Heaps, Daniela Moïsi, et al.. (2024). Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.. SHILAP Revista de lepidopterología. 9(2). 58–78.

Choudhary, Manish C., Amy Heaps, Rinki Deo, et al.. (2024). Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response. SHILAP Revista de lepidopterología. 9(2). 79–93. 1 indexed citations

Freeman, Michael L., Mian Bazle Hossain, Shana Burrowes, et al.. (2023). Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease. Open Forum Infectious Diseases. 10(8). ofad328–ofad328. 6 indexed citations

Dalli, Jesmond, Douglas Kitch, Meagan P. O’Brien, et al.. (2023). Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention. EBioMedicine. 89. 104468–104468. 6 indexed citations

Wang, Richard J., Daniela Moïsi, Emily Chang, et al.. (2019). HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia. PLoS ONE. 14(5). e0216680–e0216680. 11 indexed citations

Mésplède, Thibault, Peter K. Quashie, Maureen Oliveira, et al.. (2015). HIV-1 Group O Resistance Against Integrase Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(1). 9–15. 12 indexed citations

Oliveira, Maureen, Thibault Mésplède, Daniela Moïsi, et al.. (2015). The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir. AIDS. 29(17). 2255–2260. 11 indexed citations

10.

Mésplède, Thibault, et al.. (2015). Dolutegravir inhibits HIV-1 Env evolution in primary human cells. AIDS. 29(6). 659–665. 9 indexed citations

11.

Hardy, Isabelle, Bluma Brenner, Peter K. Quashie, et al.. (2014). Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance. Journal of Antimicrobial Chemotherapy. 70(2). 405–411. 32 indexed citations

12.

Invernizzi, Cédric, Dimitrios Coutsinos, Maxwel C. Oliveira, et al.. (2013). The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites. Journal of Antimicrobial Chemotherapy. 68(10). 2192–6. 5 indexed citations

13.

Wainberg, Mark A., Maxwel C. Oliveira, Eugene L. Asahchop, et al.. (2012). The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors. Journal of Antimicrobial Chemotherapy. 67(4). 988–994. 16 indexed citations

14.

Coutsinos, Dimitrios, Cédric Invernizzi, Daniela Moïsi, et al.. (2011). A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1. PLoS ONE. 6(5). e20208–e20208. 36 indexed citations

15.

Ntemgwa, Michel, M. John Gill, Bluma Brenner, Daniela Moïsi, & Mark A. Wainberg. (2008). Discrepancies in Assignment of Subtype/Recombinant Forms by Genotyping Programs for HIV Type 1 Drug Resistance Testing May Falsely Predict Superinfection. AIDS Research and Human Retroviruses. 24(7). 995–1002. 11 indexed citations

16.

Ntemgwa, Michel, Thomas d’Aquin Toni, Bluma Brenner, et al.. (2008). Near Full-Length Genomic Analysis of a Novel Subtype A1/C Recombinant HIV Type 1 Isolate from Canada. AIDS Research and Human Retroviruses. 24(4). 655–659. 3 indexed citations

17.

Brenner, Bluma, Michel Roger, Jean‐Pierre Routy, et al.. (2007). High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection. The Journal of Infectious Diseases. 195(7). 951–959. 501 indexed citations breakdown →

18.

Turner, Dan, Bluma Brenner, Daniela Moïsi, Chen Liang, & Mark A. Wainberg. (2005). Substitutions in the Reverse Transcriptase and Protease Genes of HIV‐1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs. Journal of the International AIDS Society. 7(1). 69–69. 4 indexed citations

19.

Brenner, Bluma, Jean‐Pierre Routy, Yudong Quan, et al.. (2004). Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS. 18(12). 1653–1660. 96 indexed citations

20.

Brenner, Bluma, Dan Turner, Maureen Oliveira, et al.. (2003). A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 17(1). F1–F5. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact